In our search for new, safer anti-HCMV agents, we discovered that the natur
al product Arcyriaflavin A (la) was a potent inhibitor of HCMV replication
in cell culture. A series of analogues (symmetrical indolocarbazoles) was s
ynthesised to investigate structure-activity relationships in this series a
gainst a range of herpes viruses (HCMV, VZV, HSV1, and 2). This identified
a number of novel, selective and potent inhibitors of HCMV, 12,13-dihydro-2
,10-difluoro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-(6H)-dione (Id) be
ing the best example (IC50 = 40 nM, therapeutic index > 1450). Compounds de
scribed in this series were generally poor inhibitors of protein kinase C b
eta II, and no correlation was found between the ability to inhibit HCMV an
d the enzyme PKC. (C) 1999 Elsevier Science Ltd. All rights reserved.